Team | Year | Pos | G | IP | PO | A | E | Fld % | RF | Eff | ZR |
---|---|---|---|---|---|---|---|---|---|---|---|
Anchorage - SNL (R)
ANC - SNL (R)
|
2040 | 2B | 1 | 1.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Anchorage - SNL (R)
ANC - SNL (R)
|
2040 | 3B | 5 | 9.2 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2037 | 3B | 13 | 83.1 | 5 | 15 | 3 | .870 | 2.16 | .954 | -0.36 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2036 | 3B | 1 | 2.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2036 | RF | 2 | 5.1 | 1 | 0 | 0 | 1.000 | 1.69 | .000 | 0.25 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2035 | 3B | 5 | 28.0 | 1 | 3 | 1 | .800 | 1.29 | .892 | -0.15 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2035 | LF | 2 | 4.0 | 0 | 0 | 0 | .000 | 0.00 | .000 | 0.00 |
Pfizer - IFC
PFZ - IFC
|
2034 | 3B | 5 | 32.0 | 2 | 5 | 0 | 1.000 | 1.97 | 1.111 | 0.34 |
Pfizer - IFC
PFZ - IFC
|
2034 | LF | 3 | 26.0 | 8 | 0 | 1 | .889 | 2.77 | 1.076 | 0.66 |
Pfizer - IFC
PFZ - IFC
|
2034 | RF | 16 | 138.2 | 37 | 6 | 3 | .935 | 2.79 | .958 | -1.32 |
Total | 2B | 1 | 1.0 | 0 | 0 | 0 | 0.00 | ||||
Total | 3B | 29 | 155.0 | 8 | 23 | 4 | -0.18 | ||||
Total | LF | 5 | 30.0 | 8 | 0 | 1 | 0.66 | ||||
Total | RF | 18 | 144.0 | 38 | 6 | 3 | -1.07 |